- Home
- QRVO vs MEDP Comparison
QRVO vs MEDP Comparison
Compare QRVO & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QRVO
- MEDP
- Stock Information
- Founded
- QRVO 1957
- MEDP 1992
- Country
- QRVO United States
- MEDP United States
- Employees
- QRVO N/A
- MEDP N/A
- Industry
- QRVO Semiconductors
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- QRVO Technology
- MEDP Health Care
- Exchange
- QRVO Nasdaq
- MEDP Nasdaq
- Market Cap
- QRVO 10.5B
- MEDP 11.7B
- IPO Year
- QRVO 1997
- MEDP 2016
- Fundamental
- Price
- QRVO $104.28
- MEDP $342.89
- Analyst Decision
- QRVO Hold
- MEDP Buy
- Analyst Count
- QRVO 17
- MEDP 10
- Target Price
- QRVO $119.88
- MEDP $402.44
- AVG Volume (30 Days)
- QRVO 1.2M
- MEDP 385.5K
- Earning Date
- QRVO 10-29-2024
- MEDP 10-21-2024
- Dividend Yield
- QRVO N/A
- MEDP N/A
- EPS Growth
- QRVO N/A
- MEDP 27.33
- EPS
- QRVO N/A
- MEDP 10.64
- Revenue
- QRVO $4,005,013,000.00
- MEDP $2,030,048,000.00
- Revenue This Year
- QRVO $6.75
- MEDP $15.81
- Revenue Next Year
- QRVO $8.08
- MEDP $12.91
- P/E Ratio
- QRVO N/A
- MEDP $32.21
- Revenue Growth
- QRVO 25.74
- MEDP 21.36
- 52 Week Low
- QRVO $80.62
- MEDP $227.21
- 52 Week High
- QRVO $130.99
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- QRVO 51.49
- MEDP 46.60
- Support Level
- QRVO $99.26
- MEDP $331.32
- Resistance Level
- QRVO $107.33
- MEDP $357.10
- Average True Range (ATR)
- QRVO 2.58
- MEDP 8.70
- MACD
- QRVO 0.63
- MEDP 2.17
- Stochastic Oscillator
- QRVO 63.16
- MEDP 58.00
About QRVO Qorvo Inc.
Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.